PuraPharm Corporation Limited (HKG:1498)

PuraPharm Corporation Revenue

PuraPharm Corporation had revenue of 159.67M HKD in the half year ending June 30, 2026, a decrease of -23.10%. This brings the company's total for the last twelve months to 323.49M, down -6.71% year-over-year. In the year 2025, PuraPharm Corporation had annual revenue of 336.11M, down -12.03%. That makes PuraPharm Corporation the 29,294th largest company in the world by revenue and 1,743rd in Hong Kong.

• Revenue (ttm): 323.49M
• Revenue Growth: -6.71%
• P/S Ratio: 0.38
• Revenue / Employee: 703.24K
• Employees: 460
• Market Cap: 123.06M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Hong Kong CCMG 204.95M 38.7%
• Plantation 175.97M 33.3%
• Chinese Healthcare Products 96.97M 18.3%
• Clinics 51.24M 9.7%

By Geography

Chart

• Hong Kong 291.82M 86.8%
• Other Countries/Regions 41.69M 12.4%
• Mainland China 2.61M 0.8%

Fiscal year ended Dec 31, 2025 See the full PuraPharm Corporation breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	336.11M	-45.98M	-12.03%
Dec 31, 2024	382.09M	-24.77M	-6.09%
Dec 31, 2023	406.86M	-41.21M	-9.20%
Dec 31, 2022	448.07M	-211.52M	-32.07%
Dec 31, 2021	659.59M	57.78M	9.60%

Data Source: S&P Global Market Intelligence Last updated: Sep 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error